High Rates of Recurrent CMV Infection in D+/R- Liver Transplant Recipients with Pre-emptive Therapy

被引：0
|
作者：
Massih, R. Abdel [1 ]
Bogdanovich, T. [1 ]
Carvalho, F.
Minces, L. [1 ]
Kwak, E. [1 ]
Hughes, C. [1 ]
Clancy, C. [1 ]
Nguyen, M. H. [1 ]
Humar, A. [1 ]
Silveira, F. [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA 15260 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2012年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1498
引用
收藏
页码：468 / 469
页数：2
相关论文
共 50 条
  • [1] Prophylaxis vs Preemptive Therapy for Cytomegalovirus (CMV) Disease in (D+/R-) Liver Transplant Recipients
    Bodro, Marta M.
    Llado, Laura L.
    Sabe, Nuria N.
    Niubo, Jordi J.
    Carratala, Jordi J.
    Baliellas, Carme C.
    Fabregat, Joan J.
    LIVER TRANSPLANTATION, 2011, 17 (06) : S235 - S235
  • [2] Pre-emptive CMV therapy versus universal CMV prophylaxis in renal transplant recipients
    Rebecca Kelsey
    Nature Reviews Nephrology, 2012, 8 (11) : 614 - 614
  • [3] Pre-Emptive Therapy for CMV in High-Risk Liver Transplant Recipients: A Real-World Application
    Sigler, R. K.
    Humar, A.
    Hughes, C.
    Francis, F.
    Kwak, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S396 - S396
  • [4] The pattern of CMV reactivation in allogeneic transplant recipients treated with pre-emptive therapy
    Farah, N.
    McCue, J.
    Sawhney, H.
    Lasa, M.
    Atkins, M.
    Szydlo, R.
    Apperley, J.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S298 - S299
  • [5] PRE-EMPTIVE THERAPY FOR CMV VIREMIA IN LIVING DONOR LIVER TRANSPLANT RECIPIENTS: A SINGLE CENTRE EXPERIENCE
    Nawaz, K.
    Abbas, Y.
    Salih, M.
    Ullah, N.
    Shah, S. N.
    GUT, 2017, 66 : A10 - A10
  • [6] Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients
    Humar, A
    Mazzulli, T
    Moussa, G
    Razonable, RR
    Paya, CV
    Pescovitz, MD
    Covington, E
    Alecock, E
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (05) : 1065 - 1070
  • [7] A QUANTITATIVE ANALYSIS OF CMV INFECTION IN SOLID-ORGAN TRANSPLANT RECIPIENTS MANAGED EXCLUSIVELY ON PRE-EMPTIVE THERAPY
    Atabani, Sowsan F.
    Atkinson, Claire
    Aldridge, Robert W.
    Smith, Colette
    Harber, Mark
    Thornbun, Douglas
    Rolando, Nancy
    Emery, Vincent C.
    Griffiths, Paul D.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 175 - 175
  • [8] Pre-emptive Therapy for CMV Viremia in Living Donor Liver Transplant (LDLT) Recipients: A Single Center Experience
    Nawaz, K.
    Salih, M.
    Abbas, Y.
    Ullah, N.
    Shah, N. H.
    Dar, F. S.
    TRANSPLANTATION, 2017, 101 (05) : 323 - 324
  • [9] Effectiveness of CMV prophylaxis in donor positive recipient negative (D+/R-) liver transplant recipients.
    Alajmi, MA
    Gregor, JC
    Marotta, PJ
    GASTROENTEROLOGY, 2000, 118 (04) : A982 - A982
  • [10] Management of human cytomegalovirus infection in transplant recipients by the pre-emptive therapy approach
    Gerna, Giuseppe
    Baldanti, Fausto
    Lilleri, Daniele
    FUTURE VIROLOGY, 2009, 4 (02) : 155 - 164
12345